Health Condition 1: N00-N99- Diseases of the genitourinary system
Conditions
Interventions
Intervention1: Intranasal Oxytocin: Intranasal Oxytocin 30 units, 15 units in each nostril.
Total duration - 2 years
Control Intervention1: Intranasal normal saline: Intranasal normal saline same volu
Sponsors
DR S DHARANI
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18-64 years Undergoing elective laparoscopic gynecological surgery ASA I-II Surgery duration up to 4 hours Consented to participate
Exclusion criteria
Exclusion criteria: Psychiatric illness or antidepressant/antipsychotic use Nasal pathology or obstructed breathing History of oxytocin allergy Pregnancy or lactation If converted to laparotomy Women 64 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ?Reduction in early postoperative pain scores in the oxytocin group ?Lower intra-operative and post operative opioid use ?Reduction in anxiety scores post-op Timepoint: Pain using NRS scores will be assessed at 0,2,6,12,24 hrs. Anxiety using BAI score will be assessed preoperatively and 6 hrs postop. Intraoperative and postoperative opioid usage. | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDR S Dharani
AIIMS MANGALAGIRI
Outcome results
None listed